FREYR Battery (“FREYR”), a developer of clean, next-generation battery cell production capacity, has developed a program for the Environmental Impact Assessment (EIA) and submitted...
NRx Pharmaceuticals, a clinical-stage, biopharmaceutical company has received scientific evidence from the Israel Institute for Biological Research (IIBR) that the BriLife® vaccine may produce...
Oxitec Ltd, the leading developer of biological solutions to control pests that transmit disease, destroy crops and harm livestock, announced the publication of early...
